Niven Ralph's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Jan 8, 2024
- Accession no.
- 0001415889-24-000818
- Filed
- Jan 8, 2024
- Trade date
- Jan 5, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 5 derivative transactions. Open-market sales total $88.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Niven RalphCIK 0001168060 | Officer (CHIEF SCIENTIFIC OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Common Stock | MOption exerciseAcquired | +1,400 | $1.74 | +$2,436 | 3,009 | Direct | |
| Jan 5, 2024 | Common Stock | MOption exerciseAcquired | +3,200 | $2.14 | +$6,848 | 6,209 | Direct | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −2,126 | $18.67 | −$39,692.42 | 4,083 | Direct | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −2,474 | $19.57 | −$48,416.18 | 1,609 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Common Stock | MOption exerciseDisposed | −900 | $0.00 | $0 | 14,208 | Direct | |
| Jan 5, 2024 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 9,588 | Direct | |
| Jan 5, 2024 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 11,394 | Direct | |
| Jan 5, 2024 | Common Stock | MOption exerciseDisposed | −1,200 | $0.00 | $0 | 36,108 | Direct | |
| Jan 5, 2024 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 43,232 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.